Cargando…
Fast fluorescence in situ hybridisation for the enhanced detection of MET in non-small cell lung cancer
The c-Met/hepatocyte growth factor receptor pathway is frequently dysregulated in multiple cancer types, including non-small cell lung cancer (NSCLC). MET amplification has been shown to develop as a resistance mechanism to treatment in NSCLC. The identification of increased MET copy number within t...
Autores principales: | Duncan, David Jonathan, Vandenberghe, Michel Erminio, Scott, Marietta Louise Juanita, Barker, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6793848/ https://www.ncbi.nlm.nih.gov/pubmed/31613934 http://dx.doi.org/10.1371/journal.pone.0223926 |
Ejemplares similares
-
Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation
por: Berrieman, H K, et al.
Publicado: (2004) -
EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer
por: Varella-Garcia, M, et al.
Publicado: (2009) -
Fluorescence in situ hybridisation in Carnoy’s fixed tonsil tissue
por: Clark, S. T., et al.
Publicado: (2022) -
Comparison of Chromogenic In Situ Hybridisation with Fluorescence In Situ Hybridisation and Immunohistochemistry for the Assessment of Her-2/neu Oncogene in Archival Material of Breast Carcinoma
por: Pothos, Alexios, et al.
Publicado: (2008) -
Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation
por: McCoy, Patrick J., et al.
Publicado: (2018)